Bluesail Surgical key facts
- Manufacturer of surgical instruments designed to enhance clinical precision, minimise invasiveness, and improve treatment outcomes.
- Notable investors include China Merchants Capital, Proxima Ventures (China), China Merchants Kunlun Capital, HuYangLin Capital.
- Status: Privately Held (backing).
Who backs Bluesail Surgical
4- ·Watch Bluesail Surgical: the Monday email on marks, rounds and moves
Bluesail Surgical funding rounds
No funding rounds for Bluesail Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Bluesail Surgical investors
4 investors are on record for Bluesail Surgical, including China Merchants Capital, Proxima Ventures (China), China Merchants Kunlun Capital and HuYangLin Capital.
About Bluesail Surgical
Manufacturer of surgical instruments designed to enhance clinical precision, minimise invasiveness, and improve treatment outcomes. The company offers diversified surgical devices, innovative therapeutic technologies, and dedicated R&D and manufacturing capabilities, enabling global healthcare providers to deliver safer procedures, reduced complications, and superior patient prognoses.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- bluesailsurgical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Bluesail Surgical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.